Technologies

Business Development

EU & ROW: +353 1 709 4068

U.S: +1 610 313 7045
Email: edtbusdev@elan.com

bottom

NanoCrystal Technology

Winner of Technology Innovation Award at the 2010 Drug Delivery Partnership Meeting

Technologies

Validated platform of technologies

Elan Drug Technologies has a unique platform of validated technologies to offer our clients - from Oral controlled release, delayed release, pulsatile release delivery systems as well as technology solutions for poorly water soluble compounds.

We have a complete range of capabilities from formulation development through to commercial scale manufacture in modern facilities. Our technologies are supported by robust patent estate of over 1,900 patents and pending applications.

 

NanoCrystal ® Technology

Proven

Five products launched, US $1.8B+ annual in-market sales.



Patent Protected

Over 1,000 issued/filed patents in U.S. and ROW

separator

Simple, Easy and Effective

Optimised and simplified from over 15 years of development. All dosage forms applicable. Manufactured at commercial scale.

separator

» More Information

Oral Controlled Release

Proven

17 Products currently on the market Worldwide



Patent Protected

Over 450 issued/filed patents in U.S. and ROW. Customised and robust technology platform for modified, controlled, pulsatile and delayed oral release. Manufactured to commercial scale in Europe and U.S.

separator

» More Information
 

Sign-up for updates

Click here to sign up for news and updates.

Elan Corporation, plc. Registered Office: Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland. Registered in Ireland, Number 30356.